Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis

Xiao-hui Meng1, Yi Wang, Jian-xin Zhuang

  • 1Department of Pediatrics, Shandong Provincial Hospital, Shandong University, Jinan 250021, China.

Chinese Medical Journal
|September 14, 2004
PubMed
Abstract

Insights

Matrix metalloproteinase (MMP) activity, particularly MMP-2 and MMP-9, significantly increases in viral myocarditis (VM) mice, correlating with cardiac dysfunction and collagen changes. This highlights MMPs as key markers for assessing myocardial damage.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathology

Background:

  • Matrix metalloproteinases (MMPs) are crucial in collagen degradation and implicated in heart diseases.
  • Viral myocarditis (VM) involves myocardial inflammation and damage, with MMPs potentially playing a significant role.

Purpose of the Study:

  • To investigate dynamic changes in myocardial MMP activity during VM in mice.
  • To correlate MMP activity with cardiac function and myocardial collagen levels.
  • To assess the role of MMPs in VM-related pathological lesions.

Main Methods:

  • Viral myocarditis induced in DBA/2 mice using Coxsackievirus B3 (CVB3).
  • MMP activity assessed via zymography; cardiac function measured by echocardiography (EF, FS, Vp, Vi).
  • Myocardial collagen quantified by hydroxyproline; histopathology scored using H&E staining.

Main Results:

  • MMP-2 and MMP-9 activities peaked on day 10 post-infection, significantly elevated compared to controls.
  • Cardiac function indices (EF, FS, Vp, Vi) were significantly reduced on day 10.
  • Myocardial collagen increased in the recovery stage (days 21-30); MMP activity correlated positively with histopathological scores and negatively with cardiac function.

Conclusions:

  • Myocardial MMP-2 and MMP-9 activities rise during acute VM, with increased collagen by recovery.
  • These MMP changes are linked to myocardial interstitial remodeling and cardiac dysfunction.
  • MMP activity serves as a valuable biomarker for evaluating myocardial interstitial damage and cardiac dysfunction severity in VM.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...